Basaglar is a brand-name prescription drug that can help people with diabetes manage their blood sugar levels. It contains the active drug insulin glargine, a long-acting form of insulin. Also called ...

The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) on December 16 announced that the U.S. Food and Drug Administration (FDA) granted approval for Basaglar ...

Initiators of biosimilar insulin glargine-yfgn were more likely to reside in rural areas, live in long-term care facilities, or have multiple prescribers and were less likely to have previously used ...

The upward trajectory of insulin prices in the United States seems to be hitting a speed bump, as two of the biggest manufacturers are now pledging to restrain increases and offer discounts to ...

Eli Lilly reported Thursday that its experimental weekly insulin worked as well as daily basal insulin products in two late-stage studies, paving the way for the drug to compete with a similar weekly ...

Original Medicare (parts A and B) typically doesn’t cover Basaglar, an insulin glargine medication, but Medicare Advantage (Part C) and Part D plans may offer coverage depending on their specific ...